Speakers

Mitra Tavakkoli
Mitra Tavakkoli, MD, PharmD

Executive Medical Lead
BridegBio
USA

Arun Srivastava
Arun Srivastava

Professor
University of Florida College of Medicine
USA

Jeff Chaffin
Jeff Chaffin

Market Access Strategy and Contracting Consultant
Miles Payer Strategy
USA

Hildegund Ertl
Hildegund Ertl

Professor
The Wistar Institute
USA

Rachel Legmann
Rachel Legmann

Senior Director of Technology, GCT & & Thought Leader
Repligen Corporation
USA

Sophie Blondel
Sophie Blondel

Consultant and Cell and Gene
Therapies Expert, France

Deyaa Shaheen
Deyaa Shaheen

Founder
XFDA PHARMA ADVISORS CONSULTANTING SERVICES
USA

Curtis Kugel
Curtis Kugel

Manager, ZS
USA

Rajiv Gangurde
Rajiv Gangurde

Director
Vice President, Technical Operations, Cell & Gene Therapy
Parexel
USA

Anis Khimani, Senior Strategy Leader
Anis Khimani, Ph.D.,

Senior Manager
Global Product Management,
ZeptoMetrix (an antylia scientific company)
USA

Andrew Steinsapir
Andrew Steinsapir

Director, Gene Therapy Program Lead
Deerfield Discovery and Development
USA

Mehmet Karaca
Mehmet Karaca

Director
Molecular Biology-Sequencing
Sarepta Therapeutics
USA

Terence R flotte
Terence R flotte

Professor, Provost and Dean
UMass Chan Medical School,
USA

Thierry VandenDriessche
Thierry VandenDriessche

Professor
Vrije Universiteit Brussel
Belgium

Katherine High
Katherine High

Board Member
CRISPR Therapeutics
USA

Chris A. Learn
Chris A. Learn

Senior Vice President
Cell and Gene Therapy Center of Excellence
Parexel International
USA

Daya Verma
Daya Verma, Ph.D.
(Panel Discussion)

Director
TRD Project & PORTFOLIO MANAGEMENT / TECHNICAL R&D GDD
Novartis Pharmaceuticals Corporation
USA

Amanda Moore
Amanda Moore

CEO
Angelman Syndrome Foundation
USA

Kok-Seong Lim
Kok-Seong Lim

Independent Consultant
USA

Volney L. Sheen
Volney L. Sheen, MD, PhD

Associate Professor of Neurology,
Harvard Medical School
USA

Melissa Penn
Melissa Penn

Bayer Pharmaceuticals,
USA

​Daniel C. Chung
​Daniel C. Chung

Chief Medical Officer
Beacon Therapeutics
USA

Molly S. McGlaughlin
Molly S. McGlaughlin

Chief Executive Officer
Revolution Biomanufacturing Inc
USA

Devyn Smith
Devyn Smith

Chief Executive Officer
Arbor Biotechnologies
USA

Alonza Cruse
Alonza Cruse

FDA
Director, Office of Pharmaceutical Quality Operations
USA

Shira Orr
Shira Orr

Founder & CEO
Envoya Inc.
USA

Souad Messahel
Souad Messahel

Head of Clinical Operations
Elpida Therapeutics SPC
USA

Peixin Zhu
Peixin Zhu

  C.E.O.
Horizon Biosciences
USA

For regular updates bookmark gene therapy conferences website